Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Potential of CLSPN as a therapeutic target in melanoma: a key player in melanoma progression and tumor microenvironment

Fig. 4

RNA sequencing of A2058 cells to investigate the function of CLSPN. (A) Volcano plot of the differential gene expression between CLSPN knockdown group and the control group. The red points represented significantly up-regulated gene, and the blue points represented significantly down-regulated gene. (B) The top 20 enrichment of KEGG pathway terms analysis for the differential genes.(C) Protein-protein interaction analysis of differentially expressed functional genes. (D) Molecular docking result of CLSPN/IFI44L. (E) The mRNA expression of IFI44L and downstream genes after CLSPN knockdown in A2058 by qPCR. (F) The protein levels of CLSPN, IFI44L, p-STAT1, STAT1 and XAF1 after si-CLSPN transfection by western blot. (G) The quantification results of western blot by Image J (n = 3). Data were expressed as mean ± SD. * p < 0.05 and ** p < 0.01

Back to article page